基因组编辑诱导多能干细胞解析心脏通道病变异致病性
研究从携带KCNH2 T983I错义变异的LQTS患者及健康对照提取外周血单核细胞,重编程为iPSC并分化为心肌细胞。电生理显示变异组动作电位延长、IKr密度降低,且对致心律失常药物更敏感;CRISPR/Cas9校正变异可逆转表型,提示该VUS可能为致病性。
要点
- KCNH2 T983I变异iPSC-CMs显示APD延长和IKr密度降低。
- 变异细胞对多非利特等致心律失常药物敏感性增加。
- CRISPR/Cas9校正变异可恢复正常细胞表型。
核心结论
- KCNH2 T983I这一VUS可被归类为潜在致病性变异。
研究设计与样本
- 从携带KCNH2 T983I错义变异的LQTS先证者及无关健康对照提取外周血单核细胞,用无整合仙台病毒重编程为iPSC并分化为心肌细胞。
主要发现
- 全细胞膜片钳显示VUS iPSC-CMs较健康对照iPSC-CMs动作电位时程显著延长且快速激活延迟整流钾电流密度降低。
- ICA-105574增强IKr幅度并使VUS iPSC-CMs动作电位时程恢复正常。
- VUS iPSC-CMs对多非利特、伊布利特和阿齐利特等高风险致尖端扭转药物表现出更强致心律失常倾向。
- CRISPR/Cas9选择性校正因果变异(同基因对照)使异常细胞表型正常化,而在健康对照细胞中引入纯合变异重现LQTS标志性特征。
临床怎么用
- 对于LQTS相关的VUS,可考虑采用患者iPSC-CMs结合基因编辑进行功能学验证以辅助致病性判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long QT syndrome (LQTS) is an arrhythmogenic disorder of QT interval prolongation that predisposes patients to life-threatening ventricular arrhythmias such as Torsades de pointes and sudden cardiac death. Clinical genetic testing has emerged as the standard of care to identify genetic variants in patients suspected of having LQTS. However, these results are often confounded by the discovery of variants of uncertain significance (VUS), for which there is insufficient evidence of pathogenicity. OBJECTIVES: The purpose of this study was to demonstrate that genome editing of patient-specific induced pluripotent stem cells (iPSCs) can be a valuable approach to delineate the pathogenicity of VUS in cardiac channelopathy. METHODS: Peripheral blood mononuclear cells were isolated from a carrier with a novel missense variant (T983I) in the KCNH2 (LQT2) gene and an unrelated healthy control subject. iPSCs were generated using an integration-free Sendai virus and differentiated to iPSC-derived cardiomyocytes (CMs). RESULTS: Whole-cell patch clamp recordings revealed significant prolongation of the action potential duration (APD) and reduced rapidly activating delayed rectifier K+ current (IKr) density in VUS iPSC-CMs compared with healthy control iPSC-CMs. ICA-105574, a potent IKr activator, enhanced IKr magnitude and restored normal action potential duration in VUS iPSC-CMs. Notably, VUS iPSC-CMs exhibited greater propensity to proarrhythmia than healthy control cells in response to high-risk torsadogenic drugs (dofetilide, ibutilide, and azimilide), suggesting a compromised repolarization reserve. Finally, the selective correction of the causal variant in iPSC-CMs using CRISPR/Cas9 gene editing (isogenic control) normalized the aberrant cellular phenotype, whereas the introduction of the homozygous variant in healthy control cells recapitulated hallmark features of the LQTS disorder. CONCLUSIONS: The results suggest that the KCNH2T983I VUS may be classified as potentially pathogenic.
引用
- Garg P, Oikonomopoulos A, Chen H, et al. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. J Am Coll Cardiol. 2018. PMID: 29957233. doi:10.1016/j.jacc.2018.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。